Colostrinin vs Dihexa
A neutral, side-by-side comparison of two nootropic & cognitive peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Colostrinin
Proline-rich polypeptide complex isolated from ovine (sheep) colostrum. Originally researched as an Alzheimer's disease modulator, colostrinin has shown ability to stabilize cognitive function and reduce progression in mild-to-moderate Alzheimer's patients in double-blind trials. Also studied for immune modulation and anti-aging properties via cytokine balance normalization.
Full profileDihexa
Dihexa is a synthetic hexapeptide derived from angiotensin IV, developed at Washington State University. It is considered one of the most potent nootropic peptides known — in rodent models it outperforms BDNF itself for synaptogenesis and cognitive enhancement, acting through the hepatocyte growth factor (HGF) / c-Met receptor system. Unlike most nootropics, Dihexa is highly lipophilic and can be administered transdermally or orally.
Full profile| Colostrinin | Dihexa | |
|---|---|---|
| Category | Nootropic & Cognitive | Nootropic & Cognitive |
| Also known as | PRP (proline-rich polypeptide), ND, colostrum neuropeptide, CLN, ovine proline-rich polypeptide | PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide |
| Evidence | Research-stage | Preclinical only |
| Dosing range | 100mcg–400mcg mcg, sublingual, on a 3 days on / 3 days off cycle | 10mg–20mg mg, Once daily (or every other day — long-lasting effects) |
| Administration | Sublingual tablet/drop | Oral (capsule), Transdermal (cream/lotion — lipophilicity makes this effective), Subcutaneous injection (less common) |
| Key side effects | Generally well-tolerated, Mild GI discomfort, Rare hypersensitivity (relevant for dairy protein sensitivity), Mild fatigue (initial days) | Potential for pro-proliferative effects — HGF/c-Met pathway promotes cell growth (theoretical cancer concern at high doses), Headache (uncommon), Mental fatigue if overdosed, Long half-life means effects accumulate — take every other day initially |
| Cited sources | 2 references | 2 references |
Key differences
- Evidence level differs: Colostrinin is research-stage, while Dihexa is preclinical only.
- Administration: Colostrinin — Sublingual tablet/drop; Dihexa — Oral (capsule), Transdermal (cream/lotion — lipophilicity makes this effective), Subcutaneous injection (less common).
- Dosing units differ: Colostrinin is dosed in mcg, Dihexa in mg — they operate at different scales.
- Frequency: Colostrinin is typically sublingual, on a 3 days on / 3 days off cycle; Dihexa is Once daily (or every other day — long-lasting effects).
How each works
Colostrinin
Colostrinin modulates dendritic cell maturation and shifts cytokine balance toward anti-inflammatory patterns (reduced IL-6, TNF-α; increased IL-10). In neurological models, it reduces amyloid-β aggregation, decreases oxidative stress, and upregulates NGF while modulating the HPA axis stress response. A Polish double-blind trial showed statistically significant cognitive stabilization in mild-to-moderate AD patients over 15 weeks.
Dihexa
Dihexa (PNB-0408) was developed by Joseph Harding and colleagues at WSU as a metabolically stable angiotensin IV analog. It binds hepatocyte growth factor (HGF), potentiating its interaction with the c-Met receptor — a pathway critical for dendritic branching, synapse formation, and synaptic plasticity. In rodent Alzheimer's and scopolamine-impaired models, Dihexa restored cognitive performance at doses ~7 orders of magnitude lower than BDNF. It readily crosses the blood-brain barrier due to its lipophilicity, unlike BDNF itself.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.